Novatein Biosciences Launches a New Panel of Interleukin ELISA a.k.a. IL ELISA

Woburn, MA, January 23, 2014 --(PR.com)-- Novatein Biosciences has released their new collection of Interleukin ELISA, a premier assay product of the company's assay kit portfolios. Abiding by to Novatein's goal for the detection kits, those new ELISA provides superior sensitivity and assay ranges, with a great price to try for valued customers.

Interleukins are a group of cytokines expressed by white blood cells (leukocytes). The function of the immune system depends in a large part on interleukins, which featuring autoimmune diseases or immune deficiency. The majority of interleukins are synthesized by helper CD4 T lymphocytes, as well as through monocytes, macrophages, and endothelial cells. They promote the development and differentiation of T and B lymphocytes, and hematopoietic cells.

This product release includes the following interleukins:

IL-1a ELISA
IL-1 beta ELISA
IL-2 ELISA
IL-3 ELISA
IL- 4 ELISA
IL-5 ELISA
IL-6 ELISA
IL-8 ELISA
IL-9 ELISA
IL-10 ELISA
IL-12 ELISA
IL-12/23 ELISA
IL-15 ELIS
IN-17A ELISA
IL-21 ELISA
IL-22 ELISA
IL-32a ELISA
IL-34 ELISA

Also released are other interleukin related cytokines detection kits:

MCP-1/CCL2 ELISA
IFN ELISA
GM-CSF ELISA
CCL17 ELISA
FGFb ELISA
CXCL10(TARC) ELISA

Novatein Biosciences' R&D team strives to deliver new technologies that help biomedical researchers in overcoming the challenges they face in research endeavor. Novatein Biosciences is not satisfied with current product portfolios which derive from the mature technologies like ELISA, antibodies. Novatein Biosciences is also continuing to develop innovative products like multiplex detection kits using bead based methods.